Abstract
The naturally-occurring alkaloid ibogaine, found in the West African shrub Tabernanthe iboga, possesses the ability to diminish self-administration of substances of abuse, such as cocaine, heroin and alcohol. This was the lead structure for the design of a 75-member library of N,6-disubstituted isoquinuclidines. A solution-phase method for their synthesis is described.
Keywords: addiction, ibogaine, isoquinuclidine, parallel synthesis, anti-addictive
Letters in Drug Design & Discovery
Title: Solution-Phase Parallel Synthesis of N,6-Disubstituted Isoquinuclidines as Ibogaine Analogs
Volume: 2 Issue: 1
Author(s): M. S. Levi, M. O.F. Khan and R. F. Borne
Affiliation:
Keywords: addiction, ibogaine, isoquinuclidine, parallel synthesis, anti-addictive
Abstract: The naturally-occurring alkaloid ibogaine, found in the West African shrub Tabernanthe iboga, possesses the ability to diminish self-administration of substances of abuse, such as cocaine, heroin and alcohol. This was the lead structure for the design of a 75-member library of N,6-disubstituted isoquinuclidines. A solution-phase method for their synthesis is described.
Export Options
About this article
Cite this article as:
Levi S. M., Khan O.F. M. and Borne F. R., Solution-Phase Parallel Synthesis of N,6-Disubstituted Isoquinuclidines as Ibogaine Analogs, Letters in Drug Design & Discovery 2005; 2 (1) . https://dx.doi.org/10.2174/1570180053398217
DOI https://dx.doi.org/10.2174/1570180053398217 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
No Increase in HIV Drug Resistance Mutations among Injecting Drug Users on Methadone Maintenance Therapy: A Prospective Cohort Study
Current HIV Research Medication Management Issues in Old Age: A Call for Submissions to Current Clinical Pharmacology
Current Clinical Pharmacology Progress in Developing D3 Dopamine Receptor Ligands as Potential Therapeutic Agents for Neurological and Neuropsychiatric Disorders
Current Pharmaceutical Design Effects of Maternal Obesity On Placental Phenotype
Current Vascular Pharmacology Multiple Sclerosis, Gut Microbiota and Permeability: Role of Tryptophan Catabolites, Depression and the Driving Down of Local Melatonin
Current Pharmaceutical Design Development, Recent Achievements and Current Directions of Research into GABA Uptake Inhibitors
Current Medicinal Chemistry Adherence to Antiretroviral Therapies: State of the Science
Current HIV Research An Insight into the Therapeutic Potential of Major Coffee Components
Current Drug Metabolism Combination Treatment with rt-PA is More Effective than rt-PA Alone in an in Vitro Human Clot Model
Current Neurovascular Research Cell Therapy Using Induced Pluripotent Stem Cells or Somatic Stem Cells: This is the Question
Current Stem Cell Research & Therapy Impact of CYP2D6 Genetic Variation on the Response of the Cardiovascular Patient to Carvedilol and Metoprolol
Current Drug Metabolism Propitious Profile of Peppery Piperine
Current Molecular Pharmacology Life-Threatening Respiratory Syncytial Virus Disease in Children
Current Respiratory Medicine Reviews C5a, a Therapeutic Target in Sepsis
Recent Patents on Anti-Infective Drug Discovery Non-Linear Alteration of Serotonin Transport Availability in Posttraumatic Stress Disorder Measured with 4-[<sup>18</sup>F] ADAM Positron Emission Tomography
Current Molecular Imaging (Discontinued) On the Paradigm Shift Towards Multitarget Selective Drug Design
Current Computer-Aided Drug Design Editorial (Thematic Issue: Future Trends in the Development of New Antidepressant Drugs)
Current Pharmaceutical Design Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study
CNS & Neurological Disorders - Drug Targets Regeneration in a Degenerating Brain: Potential of Allopregnanolone as a Neuroregenerative Agent
Current Alzheimer Research Current Applications of Models of Genetic Effects with Interactions Across the Genome
Current Genomics